0001225208-14-006521.txt : 20140226
0001225208-14-006521.hdr.sgml : 20140226
20140226205351
ACCESSION NUMBER: 0001225208-14-006521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140224
FILED AS OF DATE: 20140226
DATE AS OF CHANGE: 20140226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bose Supratim
CENTRAL INDEX KEY: 0001538431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 14646502
MAIL ADDRESS:
STREET 1: 11A COOLING CLOSE
CITY: SINGAPORE
STATE: U0
ZIP: 558176
4
1
doc4.xml
X0306
4
2014-02-24
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001538431
Bose Supratim
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
EVP & President, Asia-Pacific
Deferred Stock Units
2014-02-24
4
A
0
13379.0000
0.0000
A
2019-02-24
Common Stock
13379.0000
13379.0000
D
Performance Share Units
2014-02-24
4
A
0
34302.0000
0.0000
A
2015-12-31
2015-12-31
Common Stock
34302.0000
34302.0000
D
Stock Option (Right to Buy)
13.0800
2014-02-24
4
A
0
31876.0000
0.0000
A
2024-02-24
Common Stock
31876.0000
31876.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2015 upon the completion of the individual service period.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
bosepoa.txt
/s/ Lee G. Giguere, Attorney-in-Fact
2014-02-26
EX-24
2
bosepoa.txt
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes and
appoints each of Timothy A. Pratt, Vance R. Brown, Theresa R. Boni, Scott G.
Hodgdon
and Lee G. Giguere signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) prepare and execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a
Form
ID, including amendments thereto, and any other documents necessary or
appropriate
to obtain codes and passwords enabling the undersigned to make electronic
filings
with the SEC of reports required by Section 16(a) of the Securities Exchange Act
of
1934, as amended, or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigned's
capacity as an executive officer and/or director of Boston Scientific
Corporation
(the "Company"), Forms 3, 4 and 5, and amendments thereto, in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4
or 5
and file such form with the SEC and any stock exchange or similar authority;
(4) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or director of the Company, Forms 144 in accordance
with
Rule 144 of the Securities Act of 1933, as amended, and the rules and
regulations
thereunder; and
(5) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in
the best interest of, or legally required by, the undersigned, it being
understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done
by virtue of this power of attorney and the rights and powers herein granted.
The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such
capacity at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the
Securities Exchange Act of 1934, as amended, or Rule 144 of the Securities Act
of
1933, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with
respect to the undersigned's holdings of and transactions in securities issued
by
the Company, unless earlier revoked by the undersigned in a signed writing
delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 28th day of January, 2014.
/s/ Supratim Bose
____________________
Supratim Bose